Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57,595 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Integrated multi-omics analyses reveal that BCAM is associated with epigenetic modification and tumor microenvironment subtypes of clear cell renal cell carcinoma.
Zhao J, Liang J, Yang Y, Sun G, Zhang X, Zhao J, Hu X, Chen J, Zhu S, Ni Y, Zhang Y, Dai J, Wang Z, Wang Z, Zeng Y, Yao J, Chen N, Shen P, Liu Z, Zeng H. Zhao J, et al. Clin Epigenetics. 2022 Aug 8;14(1):99. doi: 10.1186/s13148-022-01319-2. Clin Epigenetics. 2022. PMID: 35941663 Free PMC article.
Genomic and transcriptomic features between primary and paired metastatic fumarate hydratase-deficient renal cell carcinoma.
Liang J, Sun G, Pan X, Zhang M, Shen P, Zhu S, Zhao J, Zheng L, Zhao J, Chen Y, Yin X, Chen J, Hu X, Zeng Y, Chen J, Wang Y, Liu Z, Yao J, Su M, Huang R, Liao B, Wei Q, Li X, Zhou Q, Liu J, Shen Y, Liu Z, Chen N, Zeng H, Zhang X. Liang J, et al. Among authors: zhao j. Genome Med. 2023 May 2;15(1):31. doi: 10.1186/s13073-023-01182-7. Genome Med. 2023. PMID: 37131267 Free PMC article.
Memory/Active T-Cell Activation Is Associated with Immunotherapeutic Response in Fumarate Hydratase-Deficient Renal Cell Carcinoma.
Chen J, Hu X, Zhao J, Yin X, Zheng L, Guo J, Chen J, Wang Y, Sheng X, Dong H, Liu X, Zhang X, Liang J, Liu H, Yao J, Liu J, Shen Y, Chen Z, He Z, Wang Y, Chen N, Nie L, Zhang M, Pan X, Chen Y, Liu H, Zhang Y, Tang Y, Zhu S, Zhao J, Dai J, Wang Z, Zeng Y, Wang Z, Huang H, Liu Z, Shen P, Zeng H, Sun G. Chen J, et al. Among authors: zhao j. Clin Cancer Res. 2024 Jun 3;30(11):2571-2581. doi: 10.1158/1078-0432.CCR-23-2760. Clin Cancer Res. 2024. PMID: 38512114 Free PMC article.
The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
Zhang Y, Chen J, Liu H, Dai J, Zhao J, Zhu S, Zhang X, Liang J, Hu X, Zhao J, Liu Z, Shen P, Sun G, Zeng H. Zhang Y, et al. Among authors: zhao j. Cancer Treat Rev. 2024 Sep;129:102787. doi: 10.1016/j.ctrv.2024.102787. Epub 2024 Jun 15. Cancer Treat Rev. 2024. PMID: 38905806 Review.
Epigenetic modification of PHLDA2 is associated with tumor microenvironment and unfavorable outcome of immune checkpoint inhibitor-based therapies in clear cell renal cell carcinoma.
Zhao J, Pan X, Wang Z, Chen Y, Liu D, Shen Y, Wei X, Xu C, Zhang X, Hu X, Chen J, Zhao J, Tang B, Sun G, Shen P, Liu Z, Zeng H, Liang J. Zhao J, et al. Eur J Med Res. 2024 Jul 20;29(1):378. doi: 10.1186/s40001-024-01939-9. Eur J Med Res. 2024. PMID: 39033192 Free PMC article.
Decade-long insights into transperineal prostate biopsy in a West China population: temporal trend, targeted and repeat biopsies, and pathological characterization: a comparative study - retrospective cohort.
Zhao J, Cai D, Chen Y, Dai J, Tu X, Chen J, Sun G, Zhang X, Liang J, Hu X, Yao J, Liu H, Zhao J, Zhang M, Chen X, Liu Z, Nie L, Chen N, Shen P, Zeng H. Zhao J, et al. Int J Surg. 2024 Oct 25. doi: 10.1097/JS9.0000000000002122. Online ahead of print. Int J Surg. 2024. PMID: 39453842 No abstract available.
57,595 results
You have reached the last available page of results. Please see the User Guide for more information.